Latest Convertible Notes News

Saluda Medical delivered FY26 revenue of US$90.2 million, beating guidance with strong US and international growth, while reporting a flat net loss of US$149.6 million amid ongoing heavy investment. The company’s FDA approval of its CAP24 paddle lead opens a new US surgical market segment.

Elevra Lithium posted a $44 million profit in FY26 after merging Sayona Mining and Piedmont Lithium, overcoming temporary mining challenges and securing full funding for the North American Lithium expansion.

Rua Bioscience's FY26 results highlight a 71% surge in customer revenue driven by international expansion, yet the company continues to face significant losses and going concern risks.

Locate Technologies (NZX: LOC) posted a NZD 3.53 million loss for FY2026 despite 7.8% revenue growth, facing refinancing uncertainty on a major debt facility due in November.

Beonic Limited grew revenue by 5.2% to $23.3 million in FY26, halving its loss and achieving positive operating cash flow, underpinned by a landmark Moroccan airport contract and product innovation.

Careteq Limited (ASX: CTQ) reported a $398K net loss for FY26 amid a strategic reset that included selling its Embedded Health Solutions business and repaying all debt. The company now pivots fully to growing its HMR Referrals platform with $3.19 million cash on hand.

Global Health Limited trimmed its FY26 net loss by 12.5% to A$758,220, driven by a 5.5% lift in recurring SaaS revenue and a 20% cut in employee costs aided by AI integration, though going concern risks remain.

Epiminder Limited reported a $42.7 million loss for FY26, driven by clinical trial and product development costs following a $125 million IPO. The company progresses its FDA-approved Minder implantable EEG monitor with a pivotal US trial and next-gen device on track for 2028 launch.

Airtasker has secured $11 million in media capital through convertible notes with oOh!media and NOVA to accelerate brand growth across Australia, supporting recent strong revenue and marketplace gains.

Flight Centre Travel Group posted record total transaction value (TTV) of $25.7 billion in FY26, with statutory profit after tax surging 38% despite a $60 million Q4 leisure profit hit from Middle East tensions. The company declared a fully franked 30c dividend and launched a new $200 million buy-back program.

Complii FinTech Solutions expanded into institutional markets with a major contract, raised $2 million via convertible notes, and facilitated $22.48 billion capital raising on its platform in FY26.

Neurizon Therapeutics has completed enrolment in its pivotal HEALEY ALS Platform Trial ahead of schedule, secured critical manufacturing and funding agreements, and reduced its net loss for FY2026 while preparing for topline results in late Q2 2027.